Not Specified (Inflammatory & Immunological)

About AbelZeta Pharma

AbelZeta Pharma is a clinical-stage biotechnology company pioneering T cell-based therapies for hematologic malignancies, solid tumors, and inflammatory/immunological diseases. The company leverages a proprietary CAR-T platform and is led by a management team with deep experience from major technology and pharmaceutical corporations. While currently a private, pre-revenue entity, it is advancing a pipeline of novel cell therapies with the aim of providing personalized treatments for challenging conditions.

Therapeutic Areas